These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 22227038)
1. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Nam EH; Lee Y; Park YK; Lee JW; Kim S Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038 [TBL] [Abstract][Full Text] [Related]
2. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression. Nam EH; Lee Y; Zhao XF; Park YK; Lee JW; Kim S Carcinogenesis; 2014 Feb; 35(2):302-14. PubMed ID: 24130169 [TBL] [Abstract][Full Text] [Related]
3. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition. Nam EH; Lee Y; Moon B; Lee JW; Kim S Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972 [TBL] [Abstract][Full Text] [Related]
5. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673 [TBL] [Abstract][Full Text] [Related]
6. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200 [TBL] [Abstract][Full Text] [Related]
7. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
8. Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Koopmansch B; Berx G; Foidart JM; Gilles C; Winkler R Biochem Biophys Res Commun; 2013 Feb; 431(4):652-7. PubMed ID: 23376074 [TBL] [Abstract][Full Text] [Related]
9. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
10. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841 [TBL] [Abstract][Full Text] [Related]
11. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related]
13. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells. Sisci D; Middea E; Morelli C; Lanzino M; Aquila S; Rizza P; Catalano S; Casaburi I; Maggiolini M; Andò S Breast Cancer Res Treat; 2010 Nov; 124(1):63-77. PubMed ID: 20052536 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
15. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Lu MH; Huang CC; Pan MR; Chen HH; Hung WC Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246 [TBL] [Abstract][Full Text] [Related]
16. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
17. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512 [TBL] [Abstract][Full Text] [Related]
18. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. Roger L; Jullien L; Gire V; Roux P J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115 [TBL] [Abstract][Full Text] [Related]
19. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309 [TBL] [Abstract][Full Text] [Related]
20. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]